Increase Access to Medicines

We are proud to invest in innovation that solves the world's most significant health challenges. But we know that’s just the start of the conversation.

Our commitment to social impact inspires how we work to expand access to our medicines and tackle complex global health challenges.

We’re making care more affordable in the United States, like launching new programs so that anyone using Lilly insulin – regardless of their insurance status – is now eligible to fill their monthly prescription for $35. And we’re improving access to quality health care around the world, including our work to make our antibody therapies available to these low- and middle-income countries, furthering our goal of reaching as many patients with unmet needs as we can, no matter where they live.

Reaching across industry boundaries, we collaborate with leading partners to reach more people and help them feel better in their daily lives. Our collective work benefits individual patients and the entire global health system.

Lilly 30x30

Globally, we’ve established a goal – Lilly 30x30 – to improve access to quality health care for 30 million people living with limited resources, every year, by 2030. This is in addition to the more than 40 million people we currently reach annually through our medicines.

Lilly 30x30 is a company-wide effort and includes strategic collaborations with external partners, such as the Bill & Melinda Gates Foundation, and donations supporting nonprofit organizations, including the Lilly Foundation, the Lilly Cares Foundation and Life for a Child.

We use a mix of philanthropy and shared value-based approaches to improve health systems and concentrate on diseases where we have deep technical expertise, including diabetes, cancer and, now, COVID-19.